ADA Scientific Sessions 2026 Abstract

Combination of Tirzepatide with CBL-514 an Adipocyte-Apoptosis Agent Improves Weight Loss Durability and Adipose Tissue Remodeling in Diet-Induced Obese Rats

By Yu-Fang Ling, Min-Zhon Liang, Yu-Wei Liu, Jun-Rui Xu

Experiments in animalsInterventions

The paper

Yu-Fang Ling, Min-Zhon Liang, Yu-Wei Liu, Jun-Rui Xu

New Taipei City

ADA Scientific Sessions 2026 Abstract, 5 Jun 2026

Presented at ADA Scientific Sessions 2026, poster 1821-P

doi.org/10.2337/db26-1821-p

Cell Metabolism8 Oct 2026
A triple-target drug cut body weight by up to 19.7% in a trial
The New England Journal of Medicine4 Oct 2026
Survodutide reduces weight in adults with diabetes and obesity
Lancet4 Oct 2026
Retatrutide reduces bodyweight in obesity and type 2 diabetes
The New England Journal of Medicine4 Oct 2026
Retatrutide reduces weight and pain in adults with obesity